ArticleThe Journal of pathology2013

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.

Yvonne T Tsang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.